Evidence map›Paper›PMID 10938113›Full record

ArticleMolecular and cellular biology2000

Vav family proteins couple to diverse cell surface receptors.

S L Moores, L M Selfors, J Fredericks, T Breit, K Fujikawa, F W Alt, J S Brugge, W Swat

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 147 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Vav2 lacks CaJournal of cell science · 2020
    Article
  8. Article
  9. Targeting Rac and Cdc42 GEFs in Metastatic Cancer.Frontiers in cell and developmental biology · 2020
    Review
  10. Article
  11. Article
  12. Article
  13. Interaction between Rho GTPases and 14-3-3 Proteins.International journal of molecular sciences · 2017
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Vav3, a GEF for RhoA, Plays a Critical Role under High Glucose Conditions.Endocrinology and metabolism (Seoul, Korea) · 2014
    Article
  20. Review

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 4 countries.

S L MooresDepartment of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA.
L M Selfors
J Fredericks
T Breit
K Fujikawa
F W Alt
J S Brugge
W Swat
Children's Hospital · TNChildren's Hospital 1 · VN

Funding

WIP in TCR signaling and actin reorganizationP01HL059561 · NHLBI · IMMUNE DISEASE INSTITUTE, INC. · PI GEHA, RAIF SALIM · 1997 to 2012
$21.8M
Mechanisms that Control IgH Variable Region Exon AssemblyR01AI020047 · NIAID · IMMUNE DISEASE INSTITUTE, INC. · PI ALT, FREDERICK W. · 1985 to 2025
$14.1M
SIGNAL TRANSDUCTION EVENTS REGULATED BY INTEGRINSR01CA078773 · NCI · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI BRUGGE, JOAN SIEFERT · 1998 to 2003
$1.7M
ASSEMBLY AND EXPRESSION OF IG VARIBLE REGION GENESR37AI020047 · NIAID · IMMUNE DISEASE INSTITUTE, INC. · PI ALT, FREDERICK W · 1991 to 2000
$323k
NCI NIH HHS CA78773NCI NIH HHS R01 CA078773NHLBI NIH HHS P01 HL059561NHLBI NIH HHS P01 HL59561NIAID NIH HHS AI20047NIAID NIH HHS R01 AI020047NIAID NIH HHS R37 AI020047
6 · The paper itself

Abstract

Vav proteins are guanine nucleotide exchange factors for Rho family GTPases which activate pathways leading to actin cytoskeletal rearrangements and transcriptional alterations. Vav proteins contain several protein binding domains which can link cell surface receptors to downstream signaling proteins. Vav1 is expressed exclusively in hematopoietic cells and tyrosine phosphorylated in response to activation of multiple cell surface receptors. However, it is not known whether the recently identified isoforms Vav2 and Vav3, which are broadly expressed, can couple with similar classes of receptors, nor is it known whether all Vav isoforms possess identical functional activities. We expressed Vav1, Vav2, and Vav3 at equivalent levels to directly compare the responses of the Vav proteins to receptor activation. Although each Vav isoform was tyrosine phosphorylated upon activation of representative receptor tyrosine kinases, integrin, and lymphocyte antigen receptors, we found unique aspects of Vav protein coupling in each receptor pathway. Each Vav protein coprecipitated with activated epidermal growth factor and platelet-derived growth factor (PDGF) receptors, and multiple phosphorylated tyrosine residues on the PDGF receptor were able to mediate Vav2 tyrosine phosphorylation. Integrin-induced tyrosine phosphorylation of Vav proteins was not detected in nonhematopoietic cells unless the protein tyrosine kinase Syk was also expressed, suggesting that integrin activation of Vav proteins may be restricted to cell types that express particular tyrosine kinases. In addition, we found that Vav1, but not Vav2 or Vav3, can efficiently cooperate with T-cell receptor signaling to enhance NFAT-dependent transcription, while Vav1 and Vav3, but not Vav2, can enhance NFkappaB-dependent transcription. Thus, although each Vav isoform can respond to similar cell surface receptors, there are isoform-specific differences in their activation of downstream signaling pathways.

Indexed as

Cell Cycle ProteinsSignal TransductionAmino Acid SequenceAnimalsCell LineCHO CellsCOS CellsCricetinaeDNA, ComplementaryEpidermal Growth FactorGuanine Nucleotide Exchange FactorsHumansIntegrinsJurkat CellsMiceMolecular Sequence DataCell Cycle ProteinsDNA, ComplementaryEpidermal Growth FactorGuanine Nucleotide Exchange FactorsIntegrinsOncogene ProteinsPlatelet-Derived Growth FactorProtein IsoformsProto-Oncogene ProteinsProto-Oncogene Proteins c-vavReceptors, Antigen, B-CellReceptors, Antigen, T-CellReceptors, Cell SurfaceTyrosineVAV1 protein, humanVav1 protein, mouseVAV2 protein, humanVav2 protein, mouseVAV3 protein, humanVav3 protein, mouse

Identifiers

PMID10938113
PMCPMC86111
OpenAlexW2142831339

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.